New boots and an old knee: Why Kylian Mbappe's injury should not be blamed on On

At that moment, Mbappe scored. France won 1-0, but in the stands people were not singing about victory; they were whispering about a limping step. He had just debuted the On boots after two decades with Nike, and Angel Villanueva, the physiotherapist who warned beforehand, was suddenly treated like a prophet. Were the new boots to blame? The question is enticing, but it is aimed at the wrong target. I keep those fourteen seconds like a broken gem; sport tends to leave more questions than answers as soon as the ball stops rolling. To understand what happened, we have to start with the On deal. The Zurich-based brand, founded in 2026 and known for running shoes, wanted to enter football. They signed Mbappe as a global brand ambassador, brought in Thierry Henry as director of football, and Roger Federer, co-owner since 2026, gave the brand credibility. When a peak-phase player leaves Nike after two decades to wear On in a competitive match, the deal is a market-entry strategy, not a simple advertising gimmick. The match followed immediately: Mbappe scored, executed a finishing move at the end of a long sprint, and left the pitch. The original Goal.com story cited a medical source confirming a tendon injury; the coach said “it doesn't look good.” But the federation label in the article was written incorrectly and the coach's name does not match public records; this entire section needs verification. Sports medicine has a term: boot acclimatisation. Changing the last, studs, stiffness, cushioning or weight alters load distribution through the ankle, knee and muscle chains. The body needs time to adapt; top clubs normally let players train gradually in new footwear before competitive use. Mbappe belongs to the group of players who depend on speed and deceleration; his explosive running and sudden stopping make him more sensitive to any change under his feet. Based on my experience following matches, I have never seen a boot model tear a tendon on its own; I have seen many players re-injure an old issue simply because they were pushed to return too early. Mbappe's record says something more important: in December he had knee trouble; in the Elche match, the difficulty returned; there were reports of a wrong-leg diagnosis and a change in Real Madrid's medical staff. He returned, scored, and then stopped. This is a pattern of recurrent injury at the same site, not a one-off incident. From a tactical angle, the goal was the final part of a long acceleration; the braking force on the knee is enormous. But football does not operate on a single variable. A tendon injury is the result of accumulated load, fixture congestion, physical foundation and injury history. The boot is part of that, but if we only look at the boot, we miss the bigger picture: Real Madrid and the France national team depend on a player at his peak, recently returned from a long injury and about to face Manchester City in the Champions League last 16. The original report did not include xG, PPDA or pressing statistics. So any analysis of performance impact remains qualitative. A player who scores and then gets injured is an availability shock, not a performance-quality signal. More striking is the public-opinion loop: the headline “Are the new boots to blame?” invites debate, yet the article itself admits speculation. The gap between headline and body is a familiar media-optimisation pattern. One physiotherapist's warning on social media, even if repeated after the incident, remains one voice in a case that needs more evidence. The warning may be foresight; it may also be self-promotion. We cannot tell. The biggest blind spot in the new-boot story is that it obscures more important matters. Real Madrid appeared in a wrong-leg misdiagnosis report; the medical department had staff changes. The club and country calendars push against each other. The most vulnerable player is the one who has just returned, not the one who has just changed boots. If the public locks onto the idea “On injured Mbappe”, the Swiss brand carries reputational risk exactly in the market it is trying to build. The original article also contains three source errors: TFF instead of FFF, the France coach's name does not match public records, and the label “World Cup record scorer” for Mbappe is inaccurate—the public record belongs to Miroslav Klose with 16 goals. Those mistakes force readers to go back to the club or federation before believing any “fact.” Football's industry is seeing a special kind of transmission: one player changing boots creates ripples through brand value, club medical governance and national-team availability. On is paying to buy a place in football culture; its market-entry strategy uses Mbappe's image and the sporting credibility of Henry and Federer. If the “boots caused the injury” story sticks, On inherits reputational damage, even if the real cause is not the shoes. Nike, the brand left behind, benefits passively from the idea that switching boots was wrong. This risk does not appear on the balance sheet, but it appears in the public mind. People buy players; I buy back the stories that have been sold; the On deal is a story being repriced every day. The question worth tracking is not “are the boots to blame” but whether Real Madrid will let Mbappe return early because of the Champions League. Does the On deal contain image clauses; will the medical staff make a conservative decision when the same knee has already broken down twice in a season? Football can forget the logo on the boot, but it will not forget the sound of a limping step after a winning night. After nearly seven decades of watching football, I still learn how the ball rolls every day; this time the lesson is simple: do not rush to condemn the boot before letting the knee tell its story. The pitch does not need a poet, but the poet needs the pitch.